TIDMCOS

Collagen Solutions PLC

28 September 2015

Collagen Solutions Plc

(the "Company" or the "Group")

Supply Agreement with Yucel

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that its subsidiary Collagen Solutions Inc. has signed a supply agreement with Turkish medical device company Yücel Medikal Ltd (Yucel)

This supply agreement covers the provision of collagen materials and support services for use in Yucel's product Lyocoll which is currently on sale in Turkey. Lyocoll is a local haemostatic used in all types of surgery to control capillary and venous bleeding as well as oozing where the conventional methods are impractical and ineffective.

Commenting on the agreement Dr Stewart White, CEO of Collagen Solutions, said: "Collagen Solutions is pleased to have signed another supply agreement with our valued customer Yucel to provide materials for their haemostatic product Lyocoll. This supply agreement further demonstrates the range of products that our medical grade collagens are suitable for and the global nature of our reach."

Senol Yucel, CEO of Yucel added: "Consistency of product and continuity of supply are two very important factors for us and we have carried out a thorough review of the capabilities of Collagen Solutions to deliver the specific collagen that we require for Lyocoll. We are therefore pleased to be able to sign this agreement with a company which we can trust to deliver a quality product for us."

Enquiries:

 
 Collagen Solutions Plc 
 David Evans, Chairman                  Tel: 07740 084 452 
 Stewart White, CEO                     Tel: 0141 648 9100 
 
 Panmure Gordon & Co (Nomad and          Tel: 0207 8862 714 
  Broker)                                 Tel: 0207 886 2905 
  Robert Naylor (Corporate Finance) 
  Maisie Atkinson (Corporate Broking) 
 
 Walbrook PR Ltd                        Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Anna Dunphy                            Mob: 07876 741 001 
 Mike Wort                              Mob: 07900 608 002

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAPGUGABUPAUAR

(END) Dow Jones Newswires

September 28, 2015 02:02 ET (06:02 GMT)

Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Healthcare Inv Charts.
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Healthcare Inv Charts.